[1] Wang D, Xie T, Ji X,et al. Evaluation of transjugular intrahepatic portosystemic shunt and modified sclerotherapy in predicting rebleeding of esophageal and gastric varices. Med Eng Phys, 2022, 110:103905. [2] Feng Q, Guan S, Zhao JR, et al. Gadobenate dimeglumine-enhanced magnetic resonance imaging can accurately predict the severity of esophageal varices and portal vein pressure in patients with hepatitis B cirrhosis. J Dig Dis, 2020, 21(2):104-111. [3] Zhou H, Zhang Z, Zhang J, et al. Performance of spleen stiffness measurement by 2D-shear wave elastography inevaluating the presence of high-risk varices: comparative analysis of idiopathic portal hypertension versus hepatitis B virus. BMC Med Imaging, 2023, 23(1):30. [4] Wang D, Zhang Z, Dong R, et al. Laparoscopic splenectomy and esophagogastric degascularization combined with fast-track principles offers greater benefit for patients with portal hypertension. Wideochir Inne Tech Maloinwazyjne, 2022, 17(2): 326-337. [5] Garbuzenko DV, Arefyegv NO. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. J Egvid Based Med, 2020, 13(4): 313-324. [6] Abd-Elsalam SM, Ezz MM, Gamalel-Din S, et al. Derivation of "Egyptian varices prediction (EGVP) index": a novel noninvasive index for diagnosing esophageal varices in HCV patients. J Adv Res, 2021, 35: 87-97. [7] 中华医学会肝病学分会. 肝硬化诊治指南. 实用肝脏病杂志, 2019, 22(6): 770-786. [8] 中华预防医学会, 中国疾病预防控制中心免疫规划中心. 中国成人乙型肝炎免疫预防技术指南. 中华流行病学杂志, 2011, 32(12): 1199-1203. [9] 戴欢, 李凯, 朱永湘, 等. 内镜下套扎和注射硬化剂治疗乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者疗效研究. 实用肝脏病杂志, 2023, 26(1): 87-90. [10] Alam R, Karim ASMB, Rukunuzzaman M, et al. Non-endoscopic predictors of esophageal varices in children with chronic liver disease and their utility in resource-constrained countries. Indian J Gastroenterol, 2019, 38(4): 310-316. [11] Rana A, Malik A, Krishnan V, et al. Doppler hemodynamic liver index and hepatic elastic modulus: advanced ultrasonographic techniques for non-invasive prediction of esophageal varices in cirrhosis. J Clin Ultrasound, 2022, 50(3): 354-363. [12] Bayani A, Asadi F, Hosseini A, et al. Performance of machine learning techniques on prediction of esophageal varices grades among patients with cirrhosis. Clin Chem Lab Med, 2022, 60(12): 1955-1962. [13] Peisen F, Ekert K, Bitzer M, et al. CT hepatic arterial perfusion index does not allow stratification of the degree of esophageal varices and bleeding risk in cirrhotic patients in Child-Pugh classes A and B. Abdom Radiol (NY), 2021, 46(12):5586-5597. [14] Zhang F, Liu T, Gao P, et al. Predictive value of a noninvasive serological hepatic fibrosis scoring system in cirrhosis combined with oesophageal varices. Can J Gastroenterol Hepatol, 2018, 2018:7671508. [15] Colecchia A, Montrone L, Scaioli E, et al. Measurement of spleen stiffness toevaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology, 2012, 143(3):646-654. [16] Zheng B, Liu XL, Fan R, et al. The landscape of cell-free HBV integrations and mutations in cirrhosis and hepatocellular carcinoma patients. Clin Cancer Res, 2021, 27(13):3772-3783. [17] Liang YF, Wang SQ, Pan ZY, et al. Differentiation between alcohol-associated cirrhosis and hepatitis B-associated cirrhosis based on hepatic complications and psychological symptoms. J Res Med Sci, 2023, 28:37. [18] Wang Q, Zhao H, Deng Y, et al. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis. J Hepatol, 2022, 77(6):1564-1572. [19] Zhu DM, Xie J, Ye CY, et al. Risk of hepatocellular carcinoma remains high in patients with HBV-related decompensated cirrhosis and long-term antiviral therapy. Can J Gastroenterol Hepatol, 2020, 2020:8871024. [20] 胡倩, 杜国强, 王建英, 等. 肝硬化食管胃底静脉曲张内镜治疗术后感染危险因素及实验室指标早期预测价值. 中华医院感染学杂志, 2022, 32(10): 1514-1518. |